Baron Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.16M Buy
1,004
+63
+7% +$74.3K 0.3% 39
2026
Q2
$1.13M Buy
941
+42
+5% +$42.9K 0.29% 41
2026
Q1
$827K Buy
899
+61
+7% +$61.8K 0.25% 54
2025
Q4
$901K Buy
838
+170
+25% +$163K 0.28% 48
2025
Q3
$510K Buy
668
+26
+4% +$19.3K 0.17% 86
2025
Q2
$501K Buy
642
+15
+2% +$11.7K 0.18% 80
2025
Q1
$518K Buy
627
+87
+16% +$72.4K 0.23% 72
2024
Q4
$417K Sell
540
-10
-2% -$8.28K 0.2% 79
2024
Q3
$487K Buy
550
+133
+32% +$120K 0.23% 65
2024
Q2
$377K Sell
417
-28
-6% -$22.4K 0.2% 79
2024
Q1
$346K Buy
445
+38
+9% +$27K 0.18% 96
2023
Q4
$237K Buy
407
+11
+3% +$6.42K 0.13% 143
2023
Q3
$213K Buy
+396
New +$204K 0.14% 128

Other funds holding LLY

Baron Wealth Management's LLY Position: Q3 2026 in Review

Baron Wealth Management increased its Eli Lilly (LLY) stake by 6.7% in Q3 2026, buying an estimated $74.3K and bringing the position to 1,004 shares worth $1.16M. The position accounts for 0.3% of the portfolio, ranked #39.

Baron Wealth Management first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Baron Wealth Management held 1,004 shares of Eli Lilly worth $1.16M as of Q3 2026.
  • Baron Wealth Management bought 63 Eli Lilly shares in Q3 2026, an estimated $74.3K.
  • Eli Lilly made up 0.3% of Baron Wealth Management's portfolio in Q3 2026, its #39 holding.
  • Baron Wealth Management first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Baron Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.